MicroMediome Selected as Resident Startup at Seoul Bio Hub MicroMediome has been selected as one of 12 promising startups to join Seoul...

MicroMediome, a bio-healthcare company specializing in microbiome-based cancer therapy and healthcare solutions, has been selected for...